Literature DB >> 354773

Carcinoembryonic antigen levels in advanced gastric carcinoma.

D J Ellis, C Speirs, R D Kingston, V S Brookes, J Leonard, P W Dykes.   

Abstract

Serial CEA levels were measured in 157 patients with advanced inoperable gastric carcinoma entered in a controlled trial of cytotoxic therapy. In 49 (31%) of cases initial levels were greater than 50 ng/ml. However, serial measurements were only possible in 57 (36%) cases and results were prognostically valuable in only 15 (9.5%) of cases.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 354773     DOI: 10.1002/1097-0142(197808)42:2<623::aid-cncr2820420231>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Upregulation of soluble resistance-related calcium-binding protein (sorcin) in gastric cancer.

Authors:  Langmei Deng; Tao Su; Aimin Leng; Xiaomei Zhang; Meihua Xu; Lu Yan; Huan Gu; Guiying Zhang
Journal:  Med Oncol       Date:  2009-11-03       Impact factor: 3.064

2.  Implications of anti-parietal cell antibodies and anti-Helicobacter pylori antibodies in histological gastritis and patient outcome.

Authors:  Ching-Chu Lo; Ping-I Hsu; Gin-Ho Lo; Kwok-Hung Lai; Hui-Hwa Tseng; Chiun-Ku Lin; Hoi-Hung Chan; Wei-Lun Tsai; Wen-Chi Chen; Nan-Jing Peng
Journal:  World J Gastroenterol       Date:  2005-08-14       Impact factor: 5.742

3.  The usefulness of CEA as an indicator for early detection and a guide to the treatment of recurrent gastric cancer.

Authors:  T Kano; T Koga; K Souda; Y Abe; T Yonemura; N Oka; K Inokuchi
Journal:  Jpn J Surg       Date:  1987-07

4.  The clinical usefulness of preoperative CEA determination in gastric cancer.

Authors:  T Koga; T Kano; K Souda; N Oka; K Inokuchi
Journal:  Jpn J Surg       Date:  1987-09

5.  Diagnosis of gastric adenocarcinoma using a scoring system: combined assay of serological markers of Helicobacter pylori infection, pepsinogen I and gastrin.

Authors:  J T Lin; W C Lee; M S Wu; J T Wang; T H Wang; C J Chen
Journal:  J Gastroenterol       Date:  1995-04       Impact factor: 7.527

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.